Bionano Genomics, Inc.
BNGO
$1.85
$0.042.21%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -24.04% | -121.02% | 84.59% | 54.52% | -172.72% |
| Total Depreciation and Amortization | -0.16% | -2.17% | 1.47% | -56.88% | 86.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -31.33% | 140.79% | -146.82% | -62.99% | 801.17% |
| Change in Net Operating Assets | -32.37% | -137.72% | -10.68% | 89.86% | 127.36% |
| Cash from Operations | -69.74% | -26.16% | 57.50% | 51.13% | 36.56% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -335.93% | 114.07% | -569.34% | 155.76% | -118.72% |
| Cash from Investing | -335.93% | 114.07% | -569.34% | 155.76% | -118.77% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | 37.24% | -18,762.50% | 99.21% | -28.20% | 93.91% |
| Issuance of Common Stock | 318.60% | -76.80% | 98.24% | -33.52% | -16.90% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -169.41% | 157.71% | -195.72% | 67.54% | 60.32% |
| Cash from Financing | 585.91% | -86.51% | 179.97% | -35.39% | 404.40% |
| Foreign Exchange rate Adjustments | 162.50% | -166.67% | -125.00% | -116.67% | 2,500.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -688.89% | 98.94% | -1,669.39% | 103.00% | -322.75% |